medigraphic.com
ISSN 1561-2988 (Print)

2020, Number 4

<< Back Next >>

Rev Cubana Farm 2020; 53 (4)

Usage of Vidatox® 30CH for relieving pain and other symptoms in inflammatory diseases

Casamayor LZ, Guevara GMM, González LS

Language: Spanish
References: 24
Page: 1-15
PDF size: 369.27 Kb.


ABSTRACT

Introduction: VIDATOX® 30CH is a homeopathic product obtained from the venom of the Cuban scorpion Rhopalurus junceus. It allows improving the quality of life of people suffering from cancer or any other disease in which the inflammatory process prevails.
Objective: To assess the effect of VIDATOX® 30CH in the relief of pain and other symptoms of patients suffering from diseases with an inflammatory component.
Methods: A prospective longitudinal study was carried out with 2541 patients who attended LABIOFAM's medical consultations during the period between 2011 and 2016 and were treated with VIDATOX® 30CH. The variables taken into account were type of disease, main symptom as reason for consultation, time at which improvement of the main symptom started, and adverse events. The characterization of the sample was carried out through the use of descriptive measures and the determination of the 95% confidence interval. Pearson's chi-square was used to compare the clinical evolution of patients by disease. McNemar's test was used to determine the difference in proportions before and after. Analysis of variance was used to compare the time at which patients experienced improvement of the main symptoms.
Results: Patients with oncological diseases predominated (2261, 88.98%), followed by degenerative diseases (132; 5.19%). Pain was the most commonly reported symptom (1431; 56.32). The majority of patients were administered VIDATOX® 30CH three times a day (1389, 54.7%). 96.92% of these patients reported improvement in pain. On average, the improvement of the main symptoms started in 74.79 days. 0.95% of the patients presented mild and transient adverse events.
Conclusions: VIDATOX® 30CH is effective in relieving pain and other symptoms in patients with oncological, autoimmune and degenerative diseases. VIDATOX® 30CH is recommended for the relief of symptoms in patients with inflammatory diseases.


REFERENCES

  1. Riveron Garrote MN, López López RJ, Viera Mesa E, Tena Rodríguez SI, Álvarez Pérez MC. Sintomatología de la picadura del alacrán azul cubano Rhopalurus Junceus. Rev Med Homeopat. 2012;5(1):13-18. DOI: 10.1016/j.homeo.2013.07.002

  2. Riveron Garrote M, Campistrou JL, Cruz O. Abordaje homeopático de diferentes afecciones en atención primaria de salud. Rev Cubana Med Gen Integr 1997 [acceso 19/10/2020];13(2):189-94. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21251997000200015&lng=es

  3. González Arias A. Apuntes para una historia sobre la medicina alternativa en cuba - IV. remedios homeopáticos y nosodes. Revista Anales de la Academia de Ciencias de Cuba. 2015 [acceso 19/10/2020];5(1). Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/197

  4. Heine H, Schmolz M. Inmunoregulation via “bystander suppression” needs minute amounts of substances-a basis for homeopathic therapy? Med Hypotheses. 2000;54(3):392- 3. DOI: 10.1054/mehy.1999.0855

  5. Bao Y, Kong X, Yang L, Liu R, Shi Z, Li W, et al . Complementary and alternative medicine for cancer pain: An overview of systematic reviews. J Evid Based Complementary Altern Med. 2014;2014:1-9. DOI: 10.1155/2014/170396

  6. Ben-Arye E; Saleem M, Nejmi M, Schiff E, Mutafoglu K, Afifi, F. et al. Integrative oncology research in the Middle East: weaving traditional and complementary medicine in supportive care. Support Care Cancer. 2012;(20):557-64. DOI: 10.1007/s00520-011-1121-0

  7. Frenkel M. Is there a role for homeopathy in cancer care? Questions and challenges. Curr Oncol Rep. 2015;17(9):43. DOI: 10.1007/s11912-015-0467-8

  8. Ahmad S, Rehman T, Abbasi WM. Homoeopathic approach for the treatment of cancer. Indian Journal of Research in Homoeopathy. 2018 [acceso 19/10/2020];12(3):157-63 Disponible en https://www.ijrh.org/article.asp?issn=0974- 7168;year=2018;volume=12;issue=3;spage=157;epage=163;aulast=Ahmad

  9. Frass M, Friehs H, Thallinger C, Sohal NK, Marosi C, Muchitsch I, et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients – A pragmatic randomized controlled trial. Complement Ther Med. 2015;23(3):309- 17. DOI: 10.1016/j.ctim.2015.03.004

  10. Unlu A, Kirca O, Ozdogan M. Homeopathy and cancer. J Oncol Sci. 2017;3(2):77-80

  11. P. Katz N. The measurement of symptoms and side effects in clinical trials of chronic pain. Contemporary Clinical Trials. 2012:(33):903-11. DOI: 10.1016/j.jons.2017.05.006

  12. Rodríguez, C. Propiedades analgésicas y antiinflamatorias del veneno del escorpión cubano Rhopalurus junceus. 2do Simposio sobre Farmacología de Productos Naturales. Farmacología, Habana 2010. OC-20, Rev. Vaccimonitor. 2010;19(2):19-92.

  13. Díaz, A. Veneno del escorpión cubano Rhopalurus junceus: del conocimiento empírico a la ciencia. 2do Simposio sobre Farmacología de productos Naturales. Farmacología, Habana 2010. OC-19, Rev. Vaccimonitor. 2010;(2):19-91.

  14. Hernández Betancourt O, Casado Hernández I, Iglesias Huerta E, Ramírez Labrada A, del Risco Ramos J, Rodríguez Pargas A. Evaluación de la toxicidad in vitro del veneno del alacrán Rophalurus junceus a través de un ensayo celular. Rev Cubana Invest Bioméd. 2009 [acceso 20/12/2020];28(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002009000100006&lng=es

  15. Sánchez Hernández VC, Castro Morillo EM, Lovio Nodarse Y, Castro Morillo AM, Rodríguez Castro E. Medicamentos homeopáticos en el tratamiento del climaterio y la menopausia: una revisión. Rev Med Electrón. 2018 [acceso 20/12/2020];40(5) Disponible en: https://medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=84012

  16. Claramunt Palou V. Estudio observacional: casos de cáncer tratados con homeopatía en Euskadi/Navarra entre 2013 y 2015. Revista Médica de Homeopatía. 2016;9(3):89-98. DOI: 10.1016/j.homeo.2016.10.001

  17. Forero Perdomo JC, Escalona Veloz R. Terapia combinada de homeopatía y Su Jok en pacientes con herpes zóster. MEDISAN. 2015 [acceso 23/07/2018];19(3):354-65. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029- 30192015000300009&lng=es

  18. Roque Maciques A., Pérez Méndez D. VIDATOX® 30CH, una esperanza para la vida, Revista Labiofam 2011 [acceso 11/04/2013];(3). Disponible en http://revistas.labiofamcuba.com/articulo/vidatox%C2%AE-30ch-una-esperanza-para-lavida. html

  19. Danno K, Joubert C, Duru G, Vetel J-M. Physician practicing preferences for conventional or homeopathic medicines in elderly subjects with musculoskeletal disorders in the EPI3-MSD cohort. Clinical Epidemiology. 2014;6:333-341. DOI: 10.2147/CLEP.S64049

  20. Boehm K, Raak C, Cramer H, Lauche R, Ostermann T. Homeopathy in the treatment of fibromyalgia -- A comprehensive literature-review and meta-analysis. Complementary Therapies In Medicine. 2014;(4):731-42 DOI: 10.1016/j.ctim.2014.06.005

  21. Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? British Homeopathic Journal. 2000;89:S35-38.

  22. Endrizzi C, Rossi E, Crudell L, Garibaldi D. Harm in homeopathy: aggravations, adverse drug events or medication errors? Homeopathy. 2005;94(4):233-40.

  23. Gravia S, Ernst E. Homeopathic aggravations: a systematic review of randomized, placebo-controlled clinical trials. Homeopathy. 2003;92:92-8.

  24. Macias EC, Asbun J. Frecuencia de eventos adversos en prescripciones homeopáticas en el Hospital Juárez de México. Rev. Hosp. Jua Mex. 2008;75(3):190-97.




2020     |     www.medigraphic.com